Company Team Search Site Map Careers Privacy Statement
:: Home
:: About Us
:: R&D
:: Products
:: Services
:: Infrastucture
:: Contact us
Virchow Products
Manufacturing Facilities

Virchow’s manufacturing facility boasts a total built-up area of 1,50,000 square feet comprising of 9 modular suites of drug substance manufacturing, drug product manufacturing, warehouse, quality control and microbiology. The facility conforms to the highest standards and has been inspected by various international drug regulatory bodies including the DCGI (India), the USFDA (USA), the ANVISA (Brazil), the INVIMA (Colombia), and the PICS (Ukraine).


The facilities are equipped to manufacture :

  • Oral probiotic suspensions
  • Recombinants
  • Parenteral Biopharmaceuticals
  • Topical Biologics

Facility is provided with sophisticated and fully automatic lines suitable to handle:

  • Vial filling and Lyophilization
  • Cartridge filling
  • Prefilled syringes filling
  • Blow Fill Sealing
  • Blister packaging line
News & Events

Virchow Biotech is filing for U.S.Food and Drug administration’s (FDA) approval for its in house developed advanced wound care products.

Virchow Biotech received Drug control’s (DCGI) approval for conducting clinical trials on periogen, an indigenously developed recombinant therapeutic product for periodontal diseases

Virchow Biotech and Ranbaxy signed an MOU to market Virchow’s indigenously developed recombinant therapeutic protein for osteoporosis treatment. We are the first in the world to launch this biogeneric product